Answers are grounded in this paper and cite their sources.
The results confirm that activation of the coagulation and fibrinolytic systems and release of soluble inflammatory mediators are consistently observed in patients with severe sepsis syndrome. Interleukin-1 activity contributes to activation of these processes as documented by the reduction in surrogate activation markers during recombinant human interleukin-1 receptor antagonist treatment.
No takes yet. Share an insight, caveat, or question.
Marja A. Boermeester (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: